These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3662544)

  • 61. Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group.
    Kellie SJ; De Kraker J; Lilleyman JS; Bowman A; Pritchard J
    Eur J Cancer Clin Oncol; 1988 May; 24(5):903-8. PubMed ID: 3169095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolonged response to oral gefitinib, cyclophosphamide, and topotecan in heavily pretreated relapsed stage 4 neuroblastoma: a case report.
    Donfrancesco A; Jenkner A; De Ioris MA; Ilari I; Castellano A; De Laurentis C; Garganese MC; Milano GM; Dominici C
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):799-803. PubMed ID: 17984703
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Bladder irrigation with prostaglandin E2 in cyclophosphamide-induced hemorrhagic cystitis].
    Saito T; Ikeda Y; Ito E; Miyano K; Kawauchi K; Yokoyama M; Sato Y
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):155-7. PubMed ID: 3422144
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan.
    Tsuchida Y; Yokoyama J; Kaneko M; Uchino J; Iwafuchi M; Makino S; Matsuyama S; Takahashi H; Okabe I; Hashizume K
    J Pediatr Surg; 1992 May; 27(5):616-22. PubMed ID: 1625134
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose rapid schedule chemotherapy for disseminated neuroblastoma.
    Pearson AD; Craft AW; Pinkerton CR; Meller ST; Reid MM
    Eur J Cancer; 1992; 28A(10):1654-9. PubMed ID: 1389481
    [TBL] [Abstract][Full Text] [Related]  

  • 66. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma.
    Suita S; Zaizen Y; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Utsumi J; Takahashi H; Yokoyama J; Nishihira H
    J Pediatr Surg; 1994 Jun; 29(6):746-50. PubMed ID: 8078011
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Bilateral adrenal neuroblastoma of multicentric origin].
    Tamaro P; Fonda E; Valente M; Zanazzo GA
    Pediatr Med Chir; 1982; 4(3):321-6. PubMed ID: 7170205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.
    Dini G; Lanino E; Rogers D; Garaventa A; Perin G; Stura M; Dallorso S; Cornaglia-Ferraris P; De Bernardi B
    Med Pediatr Oncol; 1987; 15(1):18-23. PubMed ID: 3561328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy--a single institutional study.
    Kubota M; Yagi M; Kanada S; Okuyama N; Kinoshita Y; Yamazaki S; Asami K; Ogawa A; Watanabe T
    J Pediatr Surg; 2004 Sep; 39(9):1328-32. PubMed ID: 15359385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma.
    Weh HJ; Kabisch H; Landbeck G; Hossfeld DK
    J Clin Oncol; 1986 Oct; 4(10):1518-20. PubMed ID: 3463672
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of a single course of deferoxamine in neuroblastoma patients.
    Donfrancesco A; Deb G; Dominici C; Pileggi D; Castello MA; Helson L
    Cancer Res; 1990 Aug; 50(16):4929-30. PubMed ID: 2379156
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Management of refractory neuroblastoma with high-dose topotecan plus cyclophosphamide and vincristine].
    Chang J; Zhang YT; Wang LZ; Zhong XD
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):120-3. PubMed ID: 24568902
    [No Abstract]   [Full Text] [Related]  

  • 73. Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma.
    Green AA; Hayes FA; Hustu HO
    Cancer; 1981 Nov; 48(10):2310-7. PubMed ID: 7296480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neuroblastoma with intracranial involvement: an ENSG Study.
    Shaw PJ; Eden T
    Med Pediatr Oncol; 1992; 20(2):149-55. PubMed ID: 1734220
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase II study of cisplatinum and carboplatinum (CACIS) combination in advanced stage neuroblastomas.
    Frappaz D; Bouffet E; Perel Y; Stephan JL; Alos N; Grabois M; Berger C; Brunat Mentigny M; Philip T
    Med Pediatr Oncol; 1998 Jan; 30(1):9-14. PubMed ID: 9371382
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiagent chemotherapy for children with advanced neuroblastoma. A comparison of high-dose cyclophosphamide, vincristine and adriamycin therapy with James' therapy plus adriamycin.
    Hiyoshi Y; Yano H; Tanaka T; Noguchi A; Horikoshi T; Irie Y
    Kurume Med J; 1984; 31(1):1-6. PubMed ID: 6482368
    [No Abstract]   [Full Text] [Related]  

  • 77. Radioresistant sensitization of neuroblastoma by cisplatin?
    Mastrangelo S; Tornesello A; Bembo V; Rufini V; Mastrangelo R
    Med Pediatr Oncol; 2000 Jul; 35(1):77-9. PubMed ID: 10881013
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987.
    Suarez A; Hartmann O; Vassal G; Giron A; Habrand JL; Valteau D; Brugieres L; Kalifa C; Lemerle J
    Med Pediatr Oncol; 1991; 19(6):473-7. PubMed ID: 1961134
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute respiratory insufficiency during doxorubicin, cyclophosphamide, and G-CSF therapy.
    van Woensel JB; Knoester H; Leeuw JA; van Aalderen WM
    Lancet; 1994 Sep; 344(8924):759-60. PubMed ID: 7521502
    [No Abstract]   [Full Text] [Related]  

  • 80. A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
    Kushner BH; Kramer K; Modak S; Akhurst TJ; Cheung NK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1340-2. PubMed ID: 19711437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.